Clincosm LogoSign in Get a demo

PATMORE: Impact of Transfusional Practice on the Morbidity and Mortality of Patients in Intensive Care Unit

Sponsor
Centre Hospitalier Universitaire de Besancon (Other)
Overall Status
Unknown status
CT.gov ID
NCT03934112
Collaborator
(none)
150,000
Enrollment
18
Anticipated Duration (Months)

Study Details

Study Description

Brief Summary

This study will allow correlating transfusion monitoring and patients' prognostic according to the chosen outcome criteria.

These data could thus represent a basis for transfusion recommendations, except for intensive care and vital emergencies.

It will also bring information about the actual transfusion monitoring in intensive care unit (ICU), in the period following the stay in the ICU and after hospital discharge.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    150000 participants
    Observational Model:
    Cohort
    Time Perspective:
    Retrospective
    Official Title:
    Impact of Transfusional Practice on the Morbidity and Mortality of Patients in Intensive Care
    Anticipated Study Start Date :
    Jun 1, 2019
    Anticipated Primary Completion Date :
    Dec 1, 2020
    Anticipated Study Completion Date :
    Dec 1, 2020

    Outcome Measures

    Primary Outcome Measures

    1. Survival at 90 days after leaving ICU [Day 90]

      All-cause mortality 90 days after leaving ICU

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion criteria:

    • Patient admitted to medical and surgical resuscitation units of Besançon and Dijon university hospitals, all causes considered

    • Patient admitted between 1st January 2012 to 31st December 2017

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Centre Hospitalier Universitaire de Besancon

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Centre Hospitalier Universitaire de Besancon
    ClinicalTrials.gov Identifier:
    NCT03934112
    Other Study ID Numbers:
    • API/2016/72
    First Posted:
    May 1, 2019
    Last Update Posted:
    May 1, 2019
    Last Verified:
    Apr 1, 2019
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No

    Study Results

    No Results Posted as of May 1, 2019